European Network of Comprehensive Cancer Centres

Accueil
België
Bruxelles / Brussel
European Network of Comprehensive Cancer Centres

Itinéraire Site Web

Transform cancer care, research and education across Europe. OneForAll

EUnetCCC: The Largest European Initiative In Healthcare
To ensure that 90% of eligible patients have access to high-quality care

Key Facts & Goals:
📍 A total budget of €112 million, including €90 million in EU co-funding
📍 31 countries involved
📍 163 partners working together
📍 4-year project to drive impact
📍 9 work packages covering research, care, and innovation
📍 100 Comprehensive Cancer Centres by 2028 across Europe

EUnetCCC: A Unique European Plateform For :
•Building synergies between national and european-level initiatives
•European innovation in oncology
•Enhancing participation in european programs
•Accelerating the transfer from research to practice

EUnetCCC’s Ambitions: Excellence and Collaboration for Cancer Care in Europe
•Providing all patients with equitable access to precision diagnosis, innovating therapies and clinical trials via the CCCs
•Measuring and comparing clinical trials results between centers/countries; Fostering data sharing; Integrating clinical care and research in each center for innovation
•Developing network activities: in-person trainings, webinars, mentoring and pairing activities

Taking part in EUnetCCC: What impact for stakeholders? AT THE NATIONAL LEVEL
•Integration of national CCCs in a European Network, with better visibly
•Improvement of patients access to high-quality cancer treatments
•Foster national participation to European and international initiatives (eg: G7 Cancer)
•Address inequities in cancer care at the national and regional levels

FOR CANCER CENTERS
•Certification and better visibility
•Faster adoption of best practices and emerging technologies
•Use of the EUnetCCC network to test and deploy innovations
•Specific EUnetCCC fundings to develop pilot projects at the local level, in lign with the European objectives

FOR SCIENTISTS & CLINICIANS
•Preparing the next generation of European scientists
•Access to training programs
•Allowing cross-border exchanges and mentorship programs

16/10/2026

🎙️ Meet some of the high-level speakers joining us in Lisbon!

The EUnetCCC Annual Meeting 2026, "From European Ambition to Action", brings together policymakers, researchers, clinicians and patient representatives to shape the future of the European Network of Comprehensive Cancer Centres.

Among our speakers:
🔹 Ana Paula Martins, Minister of Health, Portugal
🔹 Antonio Parenti, Director for Public Health, Cancer and Health Security, European Commission
🔹 Elisabete Weiderpass, Director, International Agency for Research on Cancer (IARC)
🔹 Frederico Guanais, Deputy Head of Division, OECD

📅 26–27 November 2026
📍 Lisbon Congress Centre, Portugal
🗣️ 39 sessions · 170 speakers · 25 countries

Registration is open 👉 https://bit.ly/EUNETCCC2026

15/10/2026

A success story from our EUnetCCC partner IPO Porto: Porto.CCC has won the People’s Choice Award at the REGIOSTARS Awards 2026! 🏆

Developed jointly by the Instituto Português de Oncologia do Porto (IPO-Porto) and i3S at the University of Porto, Porto.CCC – TeamUp4Cancer received the most public votes among 25 finalists. It was the only Portuguese project and the only health project to reach the final.

More than 1,500 patients have already benefited from precision oncology through this initiative, which brings research and innovation closer to patient care.

“This is a very important vote of confidence,” said Professor Júlio Oliveira, President of the Board of Directors of IPO Porto, following the award.

As a partner in the EUnetCCC Joint Action, IPO Porto brings valuable experience in connecting research, innovation and clinical practice. This achievement illustrates the contribution that comprehensive cancer centres can make, supported by European investment and close collaboration between institutions.

For EUnetCCC, this success reflects a shared ambition: connecting expertise, research and care so that more people across Europe can access comprehensive cancer care.

Congratulations to everyone at IPO Porto and i3S whose work made this possible, and to all those who voted!

12/10/2026

Meet the experts joining us at the EUnetCCC Annual Meeting 2026 in Lisbon.

Bringing together voices from across Europe, the meeting will be an opportunity to exchange knowledge, share experiences and explore new perspectives on the future of cancer care.

Swipe through to meet the speakers who will contribute to the conversation and help shape the next steps of the Network.

📅 26 & 27 November 2026
📍 Lisbon Congress Centre

09/10/2026

The INA is coming together in Lisbon!

The 3rd Interim Network Assembly (INA) Meeting will take place in person in Lisbon, ahead of the 2nd Annual Meeting of the Joint Action EUnetCCC.

📍 Lisbon Congress Centre, Portugal
📅 25 November 2026
🕣 08:30–12:30 WET

This will be the first opportunity for all members of the EU Network of Comprehensive Cancer Centres to come together in person.

A unique opportunity to connect with colleagues from across Europe, meet the Chairs of the Network's Thematic Groups and learn how to get directly involved.

Registration is open until 20th October 2026.

Register here:
https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=_ccwzxZmYkutg7V0sn1ZEgb6Wkm8fWlGrAzy53G-tKBUMENMQ0tSRkJIREhSMkFTNUk0MFBBV01EMS4u.

See you in Lisbon!

06/10/2026

2nd Interim Network Assembly Meeting: Key Figures and Next Steps

175+ online connections. Three hours. One shared goal: building the EU Network of Comprehensive Cancer Centres.

Thank you to everyone who joined us for the 2nd Interim Network Assembly Meeting. Your participation and engagement are helping to shape a strong and collaborative network across Europe.

Next stop: Lisbon 🇵🇹

The 3rd INA Meeting will take place in person on 25 November 2026.
Swipe through the carousel to discover the key figures and what comes next 👉

03/10/2026

🎬 That's a wrap on the Molecular Tumour Board (MTB) Summit 2026!

A heartfelt thank you to all our speakers, to our hosts at IFO – IRCCS Regina Elena National Cancer Institute, and to everyone who joined us in Rome on 24–25 September.

Over two days, clinicians, pathologists, bioinformaticians, researchers, patient advocates, payers and policymakers came together around one shared question: how do we make molecular tumour boards a strong, accessible pillar of precision cancer care across Europe?

From MTB organisation and equity to patient perspectives and ethics, access to clinical trials, decision support tools, and health technology assessments and reimbursement pathways, the discussions showed how much we gain when we work across centres, countries and disciplines.

We hope everyone went home with new knowledge, fresh ideas, valuable connections and good memories. 💙

▶️ Watch the highlights video below, and stay tuned for what comes next. We look forward to continuing the discussions at the EUnetCCC annual meeting in Lisbon on 26 and 27 November!

🙏 With special thanks to our speakers:
Alberto Hernando Calvo, Anders Edsjö, Anita Eik Roald , Ann-Marie Broeske, Britt Elmedal Laursen, Claudia Valverde, Cristina Filipe Nogueira, Daniel Hübschmann, Enzo Medico, Étienne Rouleau, Francesco de Lorenzo, Gabriele Minuti, GILLES VASSAL, Giovanni Blandino, Haris Charalambous, Helene Poirel, Henriett Butz, Irene Brana, Joan Prades, Jörg Haier, Kjetil Tasken, Lise-lott Eriksson, Live Fagereng, Lorenza Landi, Martin Højgaard, Martin Jungkunz, Maud Kamal, PhD, Maximilian Kordes, Mona Krichen, Nancy Frédérickx, Olivia Tort, Patrizio Giacomini, Peter Grell, Roxana Albu, Rui Henrique, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Sebastian Lange, Sigve Nakken, Simonetta Buglioni, Stefan Fröhling, Thomas Dubois, Tiina Kahre, Wiebke Kragl

🔗 Programme and speakers: https://eunetccc.eu/events/mtb-summit-2026

02/10/2026

Gold September may be over, but the fight against childhood cancer continues all year round.

Cancer is rare in children and adolescents, yet it remains the leading cause of death from disease among young people in Europe.

At the EUnetCCC Molecular Tumour Board (MTB) Summit in Rome on 24 September, we spoke with Prof. Gilles Vassal, paediatric oncologist at Gustave Roussy Comprehensive Cancer Centre (France), about what needs to change:

👉"We need better access to new therapies for children and adolescents, and we must tackle inequalities across Europe in access to new and innovative medicines."

Closing these gaps is exactly why cooperation between Comprehensive Cancer Centres matters, so that every young patient, wherever they live, can benefit from the best available care.

🎥 Watch the full video to hear more.

30/09/2026

𝗖𝗖𝗖𝗡 𝗖𝗢𝗡𝗡𝗘𝗖𝗧𝗘𝗗: 𝗢𝗻 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆𝘀 – 𝗪𝗲 𝗖𝗮𝗿𝗲.
𝗜𝗻𝘀𝗶𝗱𝗲 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 𝗡𝗲𝘁𝘄𝗼𝗿𝗸𝘀.

Comprehensive Cancer Care Networks are built through connections: between organisations, professionals, standards, expertise, data and patient pathways.

👉 Today we launch 𝗖𝗖𝗖𝗡 𝗖𝗢𝗡𝗡𝗘𝗖𝗧𝗘𝗗, a new weekly EUnetCCC series dedicated to Comprehensive Cancer Care Networks (CCCNs).

Over six episodes, we will explore the building blocks of CCCNs: from standards and training to certification, quality measurement and patient pathways.

𝗘𝗮𝗰𝗵 𝘄𝗲𝗲𝗸, 𝘄𝗲 𝘄𝗶𝗹𝗹 𝗮𝗻𝘀𝘄𝗲𝗿 𝗮 𝗸𝗲𝘆 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻:
1️⃣ What is a Comprehensive Cancer Care Network?
2️⃣ What does a CCCN need to deliver high-quality care?
3️⃣ How can CCCNs be supported in practice?
4️⃣ How does a CCCN move towards certification?
5️⃣ How can quality of care be measured?
6️⃣ What does coordinated care look like across the patient pathway?

Together, these resources provide healthcare professionals, policymakers and patients with an overview of what defines CCCNs, helping to strengthen collaboration and support high-quality, coordinated cancer care across Europe.

6 weeks. 6 topics. 1 connected story.

Follow EUnetCCC and join us every Wednesday.

29/09/2026

The EUCCC Certification Scheme is ready — join us!

A robust, independent, impartial and peer-assessed European certification for Comprehensive Cancer Centres is now ready. More than 30 candidate centres have already started their certification journey, helping shape the future of excellence in cancer care across Europe.

We are pleased to announce the finalisation of the enhanced EUCCC Certification Scheme, following extensive validation through a field test carried out in 9 volunteer cancer centres across Europe.

Building on the lessons learned during this real-world testing phase, three key resources are now available on the EUnetCCC Portal:
✅The EUCCC Certification Scheme Manual, for centres already engaged — or wishing to engage — in the certification process
✅The latest Set of Criteria and Standards for EU Comprehensive Cancer Centres
✅The revised Self-Assessment Tool for Certification

Why does it matter?
🟣Patient first
A common European certification gives patients entering an EU-Certified Comprehensive Cancer Centre a guarantee: access to the highest standards of cancer care, the latest research advances, and the best-trained healthcare professionals. When it comes to cancer, postcode should never determine destiny.

🟣Building on solidarity
Experienced centres, clinicians, researchers and leaders are supporting their peers across Europe to meet demanding standards, drive continuous improvement, and progress towards certification.

🟣Scaling up a European platform
A shared European reference framework and common EU label will strengthen collaboration, enhance Europe's leadership in cancer care and research, boost competitiveness, and help attract top healthcare professionals.

Together, we are building a stronger, more connected European cancer ecosystem, where excellence, collaboration and patient-centred care go hand in hand.

28/09/2026

EUnetCCC invites all Network members to the 2nd Interim Network Assembly (INA) Meeting.

This session will serve as a key milestone to review progress, align strategic priorities, and strengthen collaboration across our European network as we work towards integrated, high-quality cancer care for all.

📅 5 October 2026
🕤 09:30–12:30 CET
💻 Online via Microsoft Teams

Your participation is vital to ensure our collective efforts continue to drive impact across Comprehensive Cancer Centres in Europe.

Adresse

52 Avenue André Morizet3 Boulogne-Billancourt Cedex
Brussels
9251

Site Web

https://eunetccc.eu/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque European Network of Comprehensive Cancer Centres publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.